(1 - 20 from 21
)
Exelixis and Its Partner Ipsen Announce Positive Overall Survival...
ir.exelixis.com
... by Bernard Escudier , M.D., chair, Genitourinary Oncology Committee, Institut Gustave Roussy and Thomas Powles , M.D., clinical professor ...
GU Symposium 2016: Cabozantinib Improves Upon the Standard of Care...
ascopost.com
... lead study author Bernard Escudier, MD, Chair of the Genitourinary Oncology Committee at the Institut Gustave Roussy in Villejuif, France.
sorted by relevance / date